Menu
Currency
GWAS Study

Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.

Brikell I, Wimberley T, Albiñana C et al.

34154395 PubMed ID
GWAS Study Type
8953 Participants
64 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BI
Brikell I
WT
Wimberley T
AC
Albiñana C
PE
Pedersen EM
VB
Vilhjálmsson BJ
AE
Agerbo E
DD
Demontis D
BA
Børglum AD
SA
Schork AJ
LS
LaBianca S
WT
Werge T
MO
Mors O
HD
Hougaard DM
TA
Thapar A
MP
Mortensen PB
DS
Dalsgaard S
Chapter II

Abstract

Summary of the research findings

Objective: Stimulant medications are effective for treating attention deficit hyperactivity disorder (ADHD), yet discontinuation and switch to nonstimulant ADHD medications are common. This study aimed to identify genetic, clinical, and sociodemographic factors influencing stimulant treatment initiation, discontinuation, and switch to nonstimulants in individuals with ADHD.

7,427 European ancestry cases, 1,706 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

8953
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Denmark
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.